Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD ; volume:13 ; number:1 ; day:26 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
Scientific reports ; 13, Heft 1 (26.10.2023), 1-11, 12.2023
- Creator
-
Kassianides, Xenophon
Bhandari, Sunil
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44578-6
- URN
-
urn:nbn:de:101:1-2024011511381696155944
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kassianides, Xenophon
- Bhandari, Sunil
- SpringerLink (Online service)
Other Objects (12)
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD – the exploratory randomized controlled double-blind ExplorIRON-CKD study
The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
Ferrous iron content of intravenous iron formulations
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
Oral and intravenous iron treatment alter the gut microbiome differentially in dialysis patients
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype
Iron therapy with special emphasis on intravenous administration
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD – the exploratory randomized controlled double-blind ExplorIRON-CKD study
The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
Ferrous iron content of intravenous iron formulations
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
Oral and intravenous iron treatment alter the gut microbiome differentially in dialysis patients
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype
Iron therapy with special emphasis on intravenous administration
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD – the exploratory randomized controlled double-blind ExplorIRON-CKD study
The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
Ferrous iron content of intravenous iron formulations
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
Oral and intravenous iron treatment alter the gut microbiome differentially in dialysis patients
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype